2. Gene
  3. ROS1 - ROS proto-oncogene 1, receptor tyrosine kinase Gene

ROS1 - ROS proto-oncogene 1, receptor tyrosine kinase Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Felis catus
Gene ID: 101093437 | Gene type: protein coding

About ROS1

ROS1 Products(12)

mRNA Protein Name
XM_045057952.1 XP_044913887.1 proto-oncogene tyrosine-protein kinase ROS isoform X6
XM_045057946.1 XP_044913881.1 proto-oncogene tyrosine-protein kinase ROS isoform X1
XM_045057950.1 XP_044913885.1 proto-oncogene tyrosine-protein kinase ROS isoform X4
XM_045057948.1 XP_044913883.1 proto-oncogene tyrosine-protein kinase ROS isoform X2
XM_045057951.1 XP_044913886.1 proto-oncogene tyrosine-protein kinase ROS isoform X5
XM_045057949.1 XP_044913884.1 proto-oncogene tyrosine-protein kinase ROS isoform X3
XM_045057951.1 XP_044913886.1 proto-oncogene tyrosine-protein kinase ROS isoform X5
XM_045057948.1 XP_044913883.1 proto-oncogene tyrosine-protein kinase ROS isoform X2
XM_045057946.1 XP_044913881.1 proto-oncogene tyrosine-protein kinase ROS isoform X1
XM_045057950.1 XP_044913885.1 proto-oncogene tyrosine-protein kinase ROS isoform X4
XM_045057949.1 XP_044913884.1 proto-oncogene tyrosine-protein kinase ROS isoform X3
XM_045057952.1 XP_044913887.1 proto-oncogene tyrosine-protein kinase ROS isoform X6
Protein Preferred Names Protein Names

proto-oncogene tyrosine-protein kinase ROS

c-ros oncogene 1 , receptor tyrosine kinase

Related Agents

Approval
Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-50878 Crizotinib Inhibitor 99.97% Yes
HY-12215 Lorlatinib 99.99% Yes
HY-W015913 Pyruvic acid sodium Inhibitor 99.86% Yes
HY-12678 Entrectinib 99.79% Yes
HY-103022 Repotrectinib Inhibitor 99.95% Unkown
HY-50878A Crizotinib hydrochloride 99.86% Yes
HY-145574 Iruplinalkib Inhibitor 99.62% Unkown
HY-12215R Lorlatinib (Standard) 99.92% Unkown
HY-50878B Crizotinib acetate Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (6)
Cat. No. Product Name Effect
Purity Phase
HY-131003A Taletrectinib free base Inhibitor / Phase 3
HY-131003 Taletrectinib Inhibitor 99.63% Phase 2
HY-152292 Zidesamtinib Inhibitor 99.78% Phase 2
HY-15514 Merestinib Inhibitor 99.99% Phase 2
HY-15514A Merestinib dihydrochloride Inhibitor 99.36% Phase 2
HY-155163 APG-2449 Inhibitor 98.93% Phase 1
Pre-clinical Phase
Bioactive Molecules (56)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0578 Apigenin 7-glucoside 98.98% Unkown
HY-W015913S Pyruvic acid-13C3 sodium Inhibitor 99.7% Unkown
HY-159147 SIA​​IS039 99.68% Unkown
HY-122311 Orniplabin Inhibitor 98% Unkown
HY-12678S1 Entrectinib-d8 99.82% Unkown
HY-N7798 Pennogenin 99.90% Unkown
HY-B1106 Tetrahydroxyquinone 98.0% Unkown
HY-50878S Crizotinib-d5 99.60% Unkown
HY-112801 F-1 Inhibitor 98.03% Unkown
HY-12678S Entrectinib-d4 Inhibitor / Unkown
HY-B1106A Tetrahydroxyquinone monohydrate 97.0% Unkown
HY-N10144 Shinpterocarpin Inhibitor / Unkown
HY-N1306 Sideroxylin / Unkown
HY-N2693 6,8-Diprenylorobol 98.40% Unkown
HY-W015913R Pyruvic acid sodium (Standard) Inhibitor 99.98% Unkown
HY-161358 FAK-IN-20 / Unkown
HY-111416 WY-135 Inhibitor / Unkown
HY-135509 Lorlatinib acetate / Unkown
HY-115541 BRD4-IN-41 Inhibitor / Unkown
HY-117420 CM764 Activator / Unkown
HY-120387 SMU-B Inhibitor / Unkown
HY-122311A Bis(2R,3R)-Orniplabin 95.0% Unkown
HY-123454 SKF1 / Unkown
HY-130794 ALK/ROS1-IN-1 Inhibitor / Unkown
HY-144697 p38 MAPK-IN-3 / Unkown
HY-147795 Nampt-IN-8 / Unkown
HY-150974 ROS1-IN-1 Inhibitor / Unkown
HY-153743 Protein kinase inhibitor 4 Inhibitor / Unkown
HY-155178 Antiproliferative agent-34 Inhibitor / Unkown
HY-156360 Xanthine oxidase-IN-12 Inhibitor / Unkown
HY-157391 ALK/ROS1-IN-3 Inhibitor / Unkown
HY-157437 AChE/BChE-IN-16 Inhibitor / Unkown
HY-158016 Antiproliferative agent-49 / Unkown
HY-161966 VEGFR-2-IN-52 / Unkown
HY-161975 ROS1-IN-2 Inhibitor / Unkown
HY-162311 Anticancer agent 194 / Unkown
HY-163862 PPARα agonist 3 / Unkown
HY-170418 ALK/ROS1-IN-5 / Unkown
HY-176942 JYP0322 Inhibitor / Unkown
HY-178391 SMU-037 / Unkown
HY-179052 Apoptosis inducer 50 / Unkown
HY-179527 LIG48 Inhibitor / Unkown
HY-50878AS Crizotinib-d9 hydrochloride / Unkown
HY-N11887 Linocinnamarin Inhibitor / Unkown
HY-RS12135 ROS1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS12136 Ros1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS12137 ROS1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-160172 ALK/ROS1-IN-4 Inhibitor / Unkown
HY-160172A ALK/ROS1-IN-4 hydrate Inhibitor / Unkown
HY-162488 Laccase-IN-3 Inhibitor / Unkown
HY-179710 SET-12 / Unkown
HY-50878S1 Crizotinib-d8 / Unkown
HY-50878S2 Crizotinib-d9 / Unkown
HY-B0847S Propiconazole-d7 / Unkown
HY-W587743 N1-Acetyl-5-methoxykynuramine hydrochloride Inhibitor / Unkown
HY-W927359 Fluorescein hydrazide (3,6-Dihydroxyxanthane) / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens ROS1 NCBI NCBI:6098